Resistance Testing

Virco Signs Contracts With Pharmaceutical Companies

Published in AIDS Weekly, November 5th, 2001

Virco has entered into a number of agreements to provide HIV drug resistance testing and other analytical services to pharmaceutical companies.

"These latest contracts reconfirm our position as a preferred partner to the pharmaceutical industry in determining the resistance profiles of their new drugs," commented Paul Stoffels, MD, chairman of Tibotec-Virco. "We are very pleased to be working with the pharmaceutical industry as a whole to bring new improved treatments to people living with HIV/AIDS."

The latest contract with DuPont Pharmaceuticals is to establish the resistance profile of their novel second-generation non-nucleoside reverse...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-11-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry